Impact of amino acid substitution at residue 9 of HLA-A2 on the development of acute GVHD in Korean pediatric patients receiving unrelated hematopoietic stem cell transplantation

Transpl Int. 2010 Dec;23(12):1216-22. doi: 10.1111/j.1432-2277.2010.01117.x.

Abstract

Incompatibility of human leukocyte antigen (HLA) alleles between donors and recipients of unrelated hematopoietic stem cell transplantation (UHSCT) increases the risk of acute graft-versus-host disease (GVHD). We evaluated the positional effect of amino acid substitutions in HLA molecules on severe acute GVHD in Korean pediatric recipients of UHSCT. All of 64 donor-recipient pairs were serologically matched for HLA-A, -B, and -DR loci. Only substitution at residue 9 resulting from an HLA-A*02 polymorphism was significantly associated with the risk of severe acute GVHD in patients (OR=7.0, P=0.033) on multivariate analysis. Recipients of this mismatched HLA also showed shortened overall survival (HR=9.7, P<0.001) and increased risk for transplant-related mortality (HR=9.1, P=0.027). Structural modeling showed that the amino acid substitution could alter the peptide preference of the ligand-binding pocket. A single amino acid substitution at position 9 was a major predictor of severe acute GVHD in Korean pediatric patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Asian People / genetics
  • Child
  • Child, Preschool
  • Female
  • Graft vs Host Disease / genetics*
  • HLA-A2 Antigen / genetics*
  • HLA-A2 Antigen / immunology
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / mortality
  • Histocompatibility Testing
  • Humans
  • Infant
  • Infant, Newborn
  • Leukemia, Myeloid, Acute / therapy
  • Logistic Models
  • Male
  • Models, Molecular
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Republic of Korea

Substances

  • HLA-A2 Antigen